Jordan, M. (2012). "Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin". Current Medicinal Chemistry. Anti-Cancer Agents. 2 (1): 1–17. doi:10.2174/1568011023354290. PMID12678749.
Islam, Mohd.; Iskander, Magdy (2004). "Microtubulin Binding Sites as Target for Developing Anticancer Agents". Mini-Reviews in Medicinal Chemistry. 4 (10): 1077–104. doi:10.2174/1389557043402946. PMID15579115.
Pellegrini, Federico; Budman, Daniel R (2005). "Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development". Cancer Investigation. 23 (3): 264–73. doi:10.1081/CNV-200055970. PMID15948296. S2CID45866448.
Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature Reviews Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID15057285. S2CID10228718.
Chen, Jing; Liu, Tao; Dong, Xiaowu; Hu, Yongzhou (2009). "Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors". Mini-Reviews in Medicinal Chemistry. 9 (10): 1174–90. doi:10.2174/138955709789055234. PMID19817710.
Cragg, Gordon M.; Newman, David J. (2004). "A Tale of Two Tumor Targets: Topoisomerase I and Tubulin. The Wall and Wani Contribution to Cancer Chemotherapy†". Journal of Natural Products. 67 (2): 232–44. doi:10.1021/np030420c. PMID14987065.
Kuppens, Isa (2006). "Current State of the Art of New Tubulin Inhibitors in the Clinic". Current Clinical Pharmacology. 1 (1): 57–70. doi:10.2174/157488406775268200. PMID18666378.
Ivachtchenko, Alexandre; Kiselyov, Alex; Tkachenko, Sergey; Ivanenkov, Yan; Balakin, Konstantin (2007). "Novel Mitotic Targets and Their Small-Molecule Inhibitors". Current Cancer Drug Targets. 7 (8): 766–84. doi:10.2174/156800907783220499. PMID18220536.
Attard, Gerhardt; Greystoke, Alastair; Kaye, Stan; De Bono, Johann (2006). "Update on tubulin-binding agents". Pathologie Biologie. 54 (2): 72–84. doi:10.1016/j.patbio.2005.03.003. PMID16545633.
Terwogt, Jetske M.Meerum; Schellens, Jan H.M.; Huinink, Wim W.ten Bokkel; Beijnen, Jos H. (1999). "Clinical pharmacology of anticancer agents in relation to formulations and administration routes". Cancer Treatment Reviews. 25 (2): 83–101. doi:10.1053/ctrv.1998.0107. PMID10395834.
Jordan, M. (2012). "Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin". Current Medicinal Chemistry. Anti-Cancer Agents. 2 (1): 1–17. doi:10.2174/1568011023354290. PMID12678749.
Islam, Mohd.; Iskander, Magdy (2004). "Microtubulin Binding Sites as Target for Developing Anticancer Agents". Mini-Reviews in Medicinal Chemistry. 4 (10): 1077–104. doi:10.2174/1389557043402946. PMID15579115.
Pellegrini, Federico; Budman, Daniel R (2005). "Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development". Cancer Investigation. 23 (3): 264–73. doi:10.1081/CNV-200055970. PMID15948296. S2CID45866448.
Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature Reviews Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID15057285. S2CID10228718.
Chen, Jing; Liu, Tao; Dong, Xiaowu; Hu, Yongzhou (2009). "Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors". Mini-Reviews in Medicinal Chemistry. 9 (10): 1174–90. doi:10.2174/138955709789055234. PMID19817710.
Cragg, Gordon M.; Newman, David J. (2004). "A Tale of Two Tumor Targets: Topoisomerase I and Tubulin. The Wall and Wani Contribution to Cancer Chemotherapy†". Journal of Natural Products. 67 (2): 232–44. doi:10.1021/np030420c. PMID14987065.
Kuppens, Isa (2006). "Current State of the Art of New Tubulin Inhibitors in the Clinic". Current Clinical Pharmacology. 1 (1): 57–70. doi:10.2174/157488406775268200. PMID18666378.
Ivachtchenko, Alexandre; Kiselyov, Alex; Tkachenko, Sergey; Ivanenkov, Yan; Balakin, Konstantin (2007). "Novel Mitotic Targets and Their Small-Molecule Inhibitors". Current Cancer Drug Targets. 7 (8): 766–84. doi:10.2174/156800907783220499. PMID18220536.
Attard, Gerhardt; Greystoke, Alastair; Kaye, Stan; De Bono, Johann (2006). "Update on tubulin-binding agents". Pathologie Biologie. 54 (2): 72–84. doi:10.1016/j.patbio.2005.03.003. PMID16545633.
Terwogt, Jetske M.Meerum; Schellens, Jan H.M.; Huinink, Wim W.ten Bokkel; Beijnen, Jos H. (1999). "Clinical pharmacology of anticancer agents in relation to formulations and administration routes". Cancer Treatment Reviews. 25 (2): 83–101. doi:10.1053/ctrv.1998.0107. PMID10395834.
Pellegrini, Federico; Budman, Daniel R (2005). "Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development". Cancer Investigation. 23 (3): 264–73. doi:10.1081/CNV-200055970. PMID15948296. S2CID45866448.
Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature Reviews Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID15057285. S2CID10228718.